Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Return on Assets: 2016-2020

Historic Return on Assets for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to -1.77%.

  • Outlook Therapeutics' Return on Assets fell 32.00% to -1.77% in Q2 2020 from the same period last year, while for Jun 2020 it was -1.77%, marking a year-over-year decrease of 32.00%. This contributed to the annual value of -1.75% for FY2019, which is 35.00% down from last year.
  • Latest data reveals that Outlook Therapeutics reported Return on Assets of -1.77% as of Q2 2020, which was up 47.60% from -3.38% recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Return on Assets ranged from a high of -0.70% in Q1 2018 and a low of -3.38% during Q1 2020.
  • In the last 3 years, Outlook Therapeutics' Return on Assets had a median value of -1.61% in 2019 and averaged -1.71%.
  • Per our database at Business Quant, Outlook Therapeutics' Return on Assets surged by 246bps in 2018 and then crashed by 156bps in 2019.
  • Outlook Therapeutics' Return on Assets (Quarterly) stood at -2.42% in 2016, then soared by 160bps to -0.82% in 2017, then tumbled by 103bps to -1.85% in 2018, then crashed by 59bps to -2.44% in 2019, then plummeted by 32bps to -1.77% in 2020.
  • Its Return on Assets stands at -1.77% for Q2 2020, versus -3.38% for Q1 2020 and -2.44% for Q4 2019.